# TENGION INC: Form D filings

TENGION INC, a biotechnology company in Winston-Salem, NC, filed 4 Form D notices with the SEC between 2011 and 2013. The latest, on August 7, 2013, reports $74.3 million sold of a $74.3 million offering to 22 investors.

Find out what TENGION INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20TENGION%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=TENGION%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Ftengion-inc-1296391)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20TENGION%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=TENGION%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Ftengion-inc-1296391)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina): 984 rows, by operating companies, filed since November 1, 2024, $49.20, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/north-carolina
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 3929 WESTPOINT BLVD., SUITE G, Winston-Salem, NC, 27103
- Phone: (336) 722-5855
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1296391

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 7, 2013 | New notice | $74,304,002 | $74,304,002 | $0 | 22 | Jun 28, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1296391/000158302113000003/0001583021-13-000003-index.htm) |
| Oct 10, 2012 | New notice | $15,005,251 | $15,005,251 | $0 | 15 | Oct 2, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1296391/000129639112000004/0001296391-12-000004-index.htm) |
| Sep 21, 2012 | New notice | $1,000,000 | $1,000,000 | $0 | 9 | Sep 7, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1296391/000129639112000003/0001296391-12-000003-index.htm) |
| Mar 16, 2011 | New notice | $31,354,278 | $31,354,278 | $0 | 43 | Mar 1, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1296391/000129639111000002/0001296391-11-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| DIANE L. JORKASKY | Director |  |
| LORIN J. RANDALL | Director |  |
| CARL-JOHAN L. DALSGAARD | Director |  |
| TIM L. BERTRAM | Executive Officer |  |
| JOHN L. MICLOT | Executive Officer, Director |  |
| A. BRIAN DAVIS | Executive Officer |  |
| RICHARD E. KUNTZ | Director |  |
| DAVID J. SCHEER | Director |  |

## Other biotechnology companies in North Carolina that filed recently

- [Toggle Bio](https://specstream.ai/data/form-d/company/toggle-bio-2158695) $200,000 · Oct 6, 2026
- [Swift Cardiovascular, Inc.](https://specstream.ai/data/form-d/company/swift-cardiovascular-inc-2117135) $810,000 · Sep 24, 2026
- [Aclarity Genomics, Inc.](https://specstream.ai/data/form-d/company/aclarity-genomics-inc-2153126) $4.6 million · Sep 2, 2026
- [Aer Therapeutics, Inc.](https://specstream.ai/data/form-d/company/aer-therapeutics-inc-1959576) $3 million · Aug 19, 2026

[Every Form D from the week of Aug 5, 2013](https://specstream.ai/data/form-d/week/2013-08-05) · [All recent filings in North Carolina](https://specstream.ai/data/form-d/state/north-carolina) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what TENGION INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).